poseida_thera

/Poseida Therapeutics

About Poseida Therapeutics

This author has not yet filled in any details.
So far has created 13 blog entries.

Poseida Therapeutics, Inc., Expands Board of Directors

San Diego, CA, August 5, 2015 — Poseida Therapeutics, Inc. (Poseida), a privately-held human therapeutics spinout of Transposagen Biopharmaceuticals, Inc. (Transposagen), announces the appointment of Lars Ekman, M.D., Ph.D. and Nishan de Silva, M.D. to the Company’s Board of Directors.  Dr. Ekman joins the Board as the Company’s Chairman, and Dr. de Silva is appointed President.

“We are […]

By |August 5th, 2015|News|Comments Off on Poseida Therapeutics, Inc., Expands Board of Directors

Poseida Therapeutics to Participate in Jefferies 2015 Healthcare Conference

San Diego, CA, June 1, 2015 — Poseida Therapeutics, Inc. (“Poseida”), a privately-held human therapeutics spinout of Transposagen Biopharmaceuticals, Inc. (“Transposagen”), announces that company executives are scheduled to participate in the upcoming Jefferies 2015 Healthcare Conference in New York. The Company’s presentation will be on Monday, June 1 at 3:00 pm Eastern time. Eric Ostertag, M.D. Ph.D., Poseida’s CEO, […]

By |June 1st, 2015|News|0 Comments

Poseida Therapeutics, Inc., Expands into JLABS to Foster Research Collaboration with Janssen for Development of Allogeneic CAR-T Therapies

San Diego, CA, May 28th, 2015 — Poseida Therapeutics, Inc. (“Poseida”), a privately-held human therapeutics spinout of Transposagen Biopharmaceuticals, Inc. (“Transposagen”), has announced it has begun drug development operations at its new location at JLABS in San Diego, California.

The drug development and license agreement between Transposagen and Janssen, which was announced in November of 2014, has been transferred to […]

By |May 28th, 2015|News|0 Comments